Clinical Trial Update: Does Pulmonary Daoyin of China Give Additional Benefit Over Usual Therapy in Management of Stable Chronic Obstructive Pulmonary Disease? [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating whether Pulmonary Daoyin provides additional benefit over usual therapy for stable chronic obstructive pulmonary disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: Henan University of Traditional Chinese Medicine | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: UNKNOWN